Bivalirudin in Patient at High Risk of Bleeding Undergoing Percutaneous Coronary Interventions.

Trial Profile

Bivalirudin in Patient at High Risk of Bleeding Undergoing Percutaneous Coronary Interventions.

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Mar 2015

At a glance

  • Drugs Bivalirudin (Primary) ; Heparin
  • Indications Cardiovascular disorders; Thromboembolism
  • Focus Adverse reactions
  • Acronyms NAPLES-III
  • Most Recent Events

    • 11 Mar 2015 Trial design presented at Cardiovascular Drugs and Therapy.
    • 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top